Neurological disability in leprosy: Incidence and gender association in Sergipe, Brazil

Geospatial Health

Volumn 6, Issue 3 SUPPL., 2012, Pages

  de Oliveira, Daniela Teles ^a   Bezerra, Marília Matos ^a   de Almeida, José Antônio Pacheco ^a   Duthie, Malcolm ^b   Reed, Steven ^c   de Jesus, Amelia Ribeiro ^a  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^c CNPq   (Brazil)

Author keywords

Brazil; Epidemiology; Leprosy; Neurological disability

Indexed keywords

ARTICLE; BRAZIL; DISEASE TRANSMISSION; EPIDEMIC; FEMALE; GEOGRAPHIC INFORMATION SYSTEM; GEOGRAPHIC MAPPING; GEOGRAPHY; HUMAN; INCIDENCE; LEPROSY; MALE; NEUROLOGIC DISEASE; PUBLIC HEALTH; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; STATISTICS;

BRAZIL; DISEASE OUTBREAKS; FEMALE; GEOGRAPHIC INFORMATION SYSTEMS; GEOGRAPHIC MAPPING; GEOGRAPHY; HUMANS; INCIDENCE; LEPROSY; MALE; NERVOUS SYSTEM DISEASES; PUBLIC HEALTH; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STATISTICS AS TOPIC;

EID: 84867066691     PISSN: 18271987     EISSN: 19707096     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Alves CJMA, Barreto JA, Fogagnolo L, Contin LA, Nassif PW, 2010. Avaliação do grau de incapacidade dos pacientes com diagnóstico de hanseníase em serviço de dermatologia do Estado de São Paulo. Rev Soc Bras Med Trop 43, 460-461.
2. Baboolal S, Millet J, Akpaka PE, Ramoutar D, Rastogi N, 2009. First insight into Mycobacterium tuberculosis epidemiology and genetic diversity in Trinidad and Tobago. J Clin Microbiol 47, 1911-1914.
3. Costa ALF, 2002. Hanseníase: incapacidades físicas após PQT, no período de 1994 a 1998 em Teresina-Piauí. In: 16th International Leprosy Congress. Salvador, Brazil.
4. Deepak S, 2003. Answering the rehabilitation needs of leprosy affected persons in integrated setting through primary health care services and community based rehabilitation. Indian J Lepr 75, 127-142.
5. Dias A, Cyrino EG, Lastotia JC, 2007. Knowledge and necessities of learning of physiotherapy's students about leprosy. Hansenol Int 32, 9-18.
6. Dros J, Wewerinke A, Bindels PG, van Weert HC, 2009. Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review. Ann Fam Med 7, 555-558
7. García-Rodríguez JF, Álvarez-Díaz H, Lorenzo-García MV, Mariño-Callejo A, Fernández-Rial Á, Sesma-Sánchez P, 2011. Extrapulmonary tuberculosis: epidemiology and risk factors. Enferm Infec Microbiol Clin 29, 502-509.
8. Gomes FG, Frade MAC, Foss NT, 2007. Skin ulcers in leprosy: clinical and epidemiological characteristics of patients. An Bras Dermatol 82.
9. Lana CF, Lanza FM, Meléndez GV, Branco AC, Teixeira S, Malaquias LCC, 2003. Distribuição da hanseníase Segundo sexo no Município de Governador Valadares, Minas Gerais, Brasil. Hansenol Int 28, 131-137.
10. Mastrangelo G, Scoizzato L, Fadda E, Silva GV, Santos LJ, Cegolon L, 2009. Epidemiological pattern of leprosy in an endemic area of North-East Brazil, 1996-2005. Rev Soc Bras Med Trop 42, 629-632.
11. Ministry of Health, 2010. Ministério da Saúde. Situação epidemiológica da Hanseniase no Brasil. Secretaria de Vigilância em Saúde, Brasília.
12. Miranzi SSC, Pereira LHM, Nunes AA, 2010. Perfil epidemiológico da hanseníase em um município brasileiro, no período de 2000 a 2006. Rev Soc Bras Med Trop 43, 62-67.
13. Mock BA, Nacy CA, 1988. Hormonal modulation of sex differences in resistance to Leishmania major systemic infections. Infect Immun 56, 3316-3319.
14. Moet FJ, Meima A, Oskam L, Richardus JH, 2004. Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions. Lepr Rev 75, 310-326.
15. Moschioni C, Antunes CMF, Grossi MA, 2010. Lambertucci JR. Risk factors for physical disability at diagnosis of 19,283 new cases of leprosy. Rev Soc Bras Med Trop 43, 19-22.
16. Pavani RAB, Tonolli ER, Avila SCGPD, 2008. Histopathological classification and clinical correlation of 50 leprosy c]ases from a teaching hospital, São José do Rio Preto, State São Paulo, Brazil. Medicina (Ribeirão Preto) 41, 188-195.
17. Penna GO, Pinheiro AP, Nogueira LSC, Carvalho LR, Oliveira MBB, Carreiro VP, 2008. Clinical and epidemiological study of leprosy cases in the University Hospital of Brasília: 20 years - 1985 to 2005. Rev Soc Bras Med Trop 41, 575-580.
18. Pinzan CF, Ruas LP, Casabona-Fortunato AS, Carvalho FC, Roque-Barreira MC, 2010. Immunological basis for the gender differences in murine Paracoccidioides brasiliensis infection. PLoS One 21, 5, e10757.
19. Queiroz JW, Dias GH, Nobre ML, Dias MCS, Araújo SF, Barbosa JD, Neto PB, Blackwell JM, Jeronimo SMB, 2010. Geographic information systems and applied spatial statistics are efficient tools to study Hansen's disease (leprosy) and to determine areas of greater risk of disease. Am J Trop Med Hyg 82, 306-314.
20. Raposo MT, Caminha AVQ, Heukelbach J, Sánchez-González MA, Medeiros JLA, Nemes MIB, 2011. Assessment of physical impairments in leprosy patients: a comparison between the World Health Organization (WHO) disability grade and the eye-hand-foot score. Rev Inst Med Trop São Paulo 53, 77-81.
21. Schuring RP, Richardus JH, Steyerberg EW, Pahan D, Faber WR, Oskam L, 2008. Preventing nerve function impairment in leprosy: validation and updating of a prediction rule. PLoS Negl Trop Dis 2, e283
22. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL, 2006. The continuing challenges of leprosy. Clin Microbiol Rev 19, 338-381.
23. Simon M, Scherlock J, Duthie MS, De Jesus AM, 2011. Clinical, immunological, and genetic aspects in leprosy. Drug Develop Res 72, 509-527.
24. Teixeira MAG, Silveira VM, França ER, 2010. Características epidemiológicas e clínicas das reações hansênicas em indivíduos paucibacilares e multibacilares, atendidos em dois centros de referência para hanseníase, na Cidade de Recife, Estado de Pernambuco. Rev Soc Bras Med Trop 43, 287-292.
25. Travi BL, Osorio Y, Melby PC, Chandrasekar B, Arteaga L, Saravia NG, 2002. Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania. Infect Immun 70, 2288-2296.
26. van Brakel WH, Lever P, Feenstra P, 2004. Monitoring the size of the leprosy problem: which epidemiological indicators should we use? Indian J Public Health 48, 5-16.
27. van Brakel WH, Nicholls PG, Wilder-Smith EP, Das L, Barkataki P, Lockwood DNJ, 2008. Early diagnosis of neuropathy in leprosy comparing diagnostic tests in a large prospective study (the INFIR Cohort Study). PLoS Negl Trop Dis 2, e212.
28. WHO, 2010. Wkly Epidemiol Rec 35, 332-348.